CRVS stock

Corvus Pharmaceuticals Inc (CRVS) financials · $1.04B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Corvus Pharmaceuticals Inc (CRVS) $1.04B cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$43.0M-$27.5M
Net Income-$15.3M-$62.3M
EPS (Diluted)-$0.53-$1.02
Cached annual balance sheet
LineFY2025FY2024
Total Assets$71.1M$68.9M
Current Assets$58.2M$54.4M
Cash & Equivalents$4.58M$8.74M
PP&E$220.0K$151.0K
Total Liabilities$9.91M$36.3M
Current Liabilities$9.38M$35.4M
Shareholders' Equity$61.2M$32.6M
Retained Earnings-$412.3M-$397.0M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$32.8M-$25.4M
CapEx$174.0KN/A
Investing Cash Flow-$7.80M-$27.5M
Financing Cash Flow$36.4M$49.0M
Dividends Paid$0N/A
Net Change in Cash-$4.16MN/A
Free Cash Flow-$33.0MN/A
These statements as JSON? API free 100/day

FAQ

What is CRVS P/E and revenue?

Corvus Pharmaceuticals Inc (CRVS) $1.04B cap.

What is CRVS revenue?

CRVS income-statement cache has no revenue figure yet.

Is CRVS profitable?

Corvus Pharmaceuticals Inc last cached net income is -$15.3M (FY2025).

What are CRVS total assets?

Corvus Pharmaceuticals Inc last cached total assets are $71.1M (FY2025).

What is CRVS free cash flow?

Corvus Pharmaceuticals Inc last cached free cash flow is -$33.0M (FY2025).

Not investment advice. Cached statements, not a live tape.